Parkwood LLC在Baxter股份中购买了9.46M美元,这抵消了收入,提高了2025年的指导水平。 Parkwood LLC bought $9.46M in Baxter shares, which beat earnings and raised 2025 guidance.

Parkwood LLC在Baxter International Inc.(BAX)投资946万美元,购买312 389股Q2股份,将其股份提高至0.06%。 Parkwood LLC invested $9.46 million in Baxter International Inc. ($BAX), buying 312,389 shares in Q2, raising its stake to 0.06%. 该公司在10月30日公布高额Q3收入, 报称0.69 EPS, The company posted strong Q3 earnings on October 30th, reporting $0.69 EPS, beating estimates by $0.09, and achieving 5% year-over-year revenue growth to $2.84 billion. Baxter将2025年全年EPS指导提高到2.35美元至2.40美元,Q4指导提高到0.52美元至0.57美元。 Baxter raised full-year 2025 EPS guidance to $2.35–$2.40 and Q4 guidance to $0.52–$0.57. 尽管净利润为3.09%的负差,但该公司股本回报率为17.38%,并宣布季度股息为0.01美元。 Despite a negative net margin of 3.09%, the company posted a 17.38% return on equity and declared a $0.01 quarterly dividend. 该股票的市场上限为97.2亿美元,交易额低于50天和200天移动平均数,并具有一致的“坚持”评级,目标价格为22.50美元。 The stock has a market cap of $9.72 billion, trades below its 50- and 200-day moving averages, and has a consensus "Hold" rating with a target price of $22.50.